Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
1 report, 1 independent
Updated Sep 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CVS Health
company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
MarketBeat
American personal finance blog
Related events
- MarketBeat aggregated analyst ratings for SM Energy, noting an upgrade from Truist Financial and a rating change from Raymond James Financial.
- MarketBeat aggregated analyst ratings and price targets for LightPath Technologies, Inc. on May 27, 2026.
- MarketBeat aggregates analyst ratings and targets for JBT Marel Corporation.
- MarketBeat aggregated analyst ratings and price targets for Jack Henry & Associates.
- MarketBeat aggregated analyst ratings and dropped the target price for Trane Technologies on September 1, 2026.